[Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru].
Nataly Echevarria CastroDanitza Rojo GarcíaMidori Torpoco RiveraPaola L RondanFrank García-RojasÁlvaro Taype-RondanPublished in: Revista peruana de medicina experimental y salud publica (2022)
This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.
Keyphrases
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- acute care
- ejection fraction
- newly diagnosed
- chronic kidney disease
- adverse drug
- prognostic factors
- cardiac arrest
- peritoneal dialysis
- atrial fibrillation
- venous thromboembolism
- respiratory syndrome coronavirus
- mental health
- blood pressure
- palliative care
- respiratory failure